To assess whether mucosal vaccination with adjuvanted S protein subunit vaccines afforded protective immunity to COVID-19, we immunized K18-hACE2tg mice IN with SARS-CoV-2 S protein formulated in ADJ+GLA or ADJ+CpG twice at an interval of 3 wk. This evidence concerns the gene PROS1 and COVID-19.